NL6707702A - - Google Patents
Info
- Publication number
- NL6707702A NL6707702A NL6707702A NL6707702A NL6707702A NL 6707702 A NL6707702 A NL 6707702A NL 6707702 A NL6707702 A NL 6707702A NL 6707702 A NL6707702 A NL 6707702A NL 6707702 A NL6707702 A NL 6707702A
- Authority
- NL
- Netherlands
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB25595/66A GB1171125A (en) | 1966-06-08 | 1966-06-08 | Improvements in or relating to Injectable Preparations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL6707702A true NL6707702A (cg-RX-API-DMAC10.html) | 1967-12-11 |
| NL159283B NL159283B (nl) | 1979-02-15 |
Family
ID=10230237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL6707702.A NL159283B (nl) | 1966-06-08 | 1967-06-02 | Werkwijze ter bereiding van een injecteerbaar preparaat. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3384544A (cg-RX-API-DMAC10.html) |
| BE (1) | BE699678A (cg-RX-API-DMAC10.html) |
| FR (1) | FR7316M (cg-RX-API-DMAC10.html) |
| GB (1) | GB1171125A (cg-RX-API-DMAC10.html) |
| IT (1) | IT1035004B (cg-RX-API-DMAC10.html) |
| NL (1) | NL159283B (cg-RX-API-DMAC10.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2104740A1 (cg-RX-API-DMAC10.html) * | 1970-03-17 | 1972-04-21 | Merck & Co Inc |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3678149A (en) * | 1970-01-26 | 1972-07-18 | Samuel J Prigal | Method of enhancing the action of a medicament |
| GB1502774A (en) * | 1974-06-25 | 1978-03-01 | Nat Res Dev | Immunological preparations |
| JPS53107408A (en) * | 1977-02-28 | 1978-09-19 | Yamanouchi Pharmaceut Co Ltd | Micellar preparation for rectal infusion |
| US4530832A (en) * | 1978-12-07 | 1985-07-23 | Schering Corporation | Method of vaccination for prevention of Bordetella bronchiseptica infection |
| DE3261734D1 (en) * | 1981-03-03 | 1985-02-14 | Centraal Diergeneeskundig Inst | Water-in-oil emulsion for use in the potentation of the immune system of animals |
| FR2501526A1 (fr) * | 1981-03-13 | 1982-09-17 | Montagne Noire Produits Chimiq | Nouveaux emulsionnants et leur application pour la production de vaccins |
| US4707470A (en) * | 1985-05-17 | 1987-11-17 | Smithkline Beckman Corporation | Polyene antibiotic emulsion formulation |
| GB2222770B (en) * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
| US6007840A (en) * | 1988-09-16 | 1999-12-28 | Novartis Ag | Pharmaceutical compositions comprising cyclosporins |
| US5688761A (en) * | 1991-04-19 | 1997-11-18 | Lds Technologies, Inc. | Convertible microemulsion formulations |
| DE69229779T2 (de) * | 1991-04-19 | 1999-12-23 | Lds Technologies, Inc. | Konvertierbare mikroemulsionsverbindungen |
| ATE233547T1 (de) * | 1991-06-26 | 2003-03-15 | Yamanouchi Europ Bv | Vesiculae in nichtpolaren medien |
| US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
| SG45449A1 (en) | 1992-05-13 | 1998-01-16 | Sandoz Ltd | Ophthalmic compositions |
| DK0589843T3 (da) | 1992-09-25 | 2002-04-02 | Novartis Ag | Cyclosporinholdige farmaceutiske præparater |
| JPH08505367A (ja) * | 1992-10-16 | 1996-06-11 | スミスクライン・ビーチャム・コーポレイション | 医薬用エマルジョン組成物 |
| DK17093D0 (da) * | 1993-02-15 | 1993-02-15 | Lyfjathroun H F | Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder |
| ATE218359T1 (de) | 1994-11-03 | 2002-06-15 | Novartis Erfind Verwalt Gmbh | Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung |
| ATE214603T1 (de) * | 1995-06-30 | 2002-04-15 | American Cyanamid Co | Stabile makrolide und makrolide imptstoff- zusammensetzungen |
| DE19544507B4 (de) | 1995-11-29 | 2007-11-15 | Novartis Ag | Cyclosporin enthaltende Präparate |
| US6245349B1 (en) | 1996-02-23 | 2001-06-12 | éLAN CORPORATION PLC | Drug delivery compositions suitable for intravenous injection |
| EP0928136B1 (en) | 1996-06-05 | 2003-10-22 | Ashmont Holdings Limited | Injectable compositions |
| PT988046E (pt) | 1997-01-30 | 2004-12-31 | Novartis Ag | Composicoes farmaceuticas sem oleo contendo ciclosporina a |
| CA2306090A1 (en) * | 1997-10-24 | 1999-05-06 | Christopher W. Mcdaniel | Delivery vehicles for bioactive agents and uses thereof |
| US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
| US8703095B2 (en) * | 2005-07-07 | 2014-04-22 | Sanofi Pasteur S.A. | Immuno-adjuvant emulsion |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE25721E (en) * | 1965-01-26 | Swine erysipelas vaccine | ||
| US2966443A (en) * | 1959-06-22 | 1960-12-27 | American Cyanamid Co | Trivalent poliomyelitis live virus vaccine |
| US3099601A (en) * | 1959-10-02 | 1963-07-30 | Anchor Serum Company | Bacterin in aqueous polyethylene, mineral oil emulsion |
| US3096249A (en) * | 1960-05-10 | 1963-07-02 | Samuel J Prigal | Emulsion composition |
| GB914894A (en) * | 1960-08-12 | 1963-01-09 | Beecham Res Lab | Injectable pharmaceutical media |
| US3149036A (en) * | 1961-10-16 | 1964-09-15 | Merck & Co Inc | Adjuvant vaccine with aluminum monostearate, mannide monooleate, vegetable oil, and an aqueous phase immunolgical agent |
| US3185625A (en) * | 1961-11-08 | 1965-05-25 | Brown Ethan Allan | Injectionable substances |
-
1966
- 1966-06-08 GB GB25595/66A patent/GB1171125A/en not_active Expired
-
1967
- 1967-06-01 US US642727A patent/US3384544A/en not_active Expired - Lifetime
- 1967-06-02 NL NL6707702.A patent/NL159283B/xx unknown
- 1967-06-06 IT IT37275/67A patent/IT1035004B/it active
- 1967-06-08 BE BE699678D patent/BE699678A/xx unknown
- 1967-09-05 FR FR119939A patent/FR7316M/fr not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2104740A1 (cg-RX-API-DMAC10.html) * | 1970-03-17 | 1972-04-21 | Merck & Co Inc |
Also Published As
| Publication number | Publication date |
|---|---|
| FR7316M (cg-RX-API-DMAC10.html) | 1969-10-06 |
| GB1171125A (en) | 1969-11-19 |
| DE1617502A1 (de) | 1972-02-10 |
| NL159283B (nl) | 1979-02-15 |
| IT1035004B (it) | 1979-10-20 |
| US3384544A (en) | 1968-05-21 |
| BE699678A (cg-RX-API-DMAC10.html) | 1967-12-08 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| VJC | Lapsed due to non-payment of the due maintenance fee for the patent or patent application | ||
| NL80 | Information provided on patent owner name for an already discontinued patent |
Owner name: GLAXO LAB |